{"originalText": "左乳腺癌术后5年，骨、肝转移2年。2009-11-26TXT+TSPA2周期，疗效评价不明显，改用TXT+DDP共用5周期，2周期评效PR，5周期评效维持PR。2010-6-30行两侧卵巢切除术，2010-7-14始服来曲唑至2011-11，复查PD。患者要求门诊化疗，给予GX方案（GEM 850MG/M2 1.6 D1,8, XELODA 1250MG/M2 2.0 BID D1-14)，因经济困难，未行GX方案化疗。于2011-11-22始给予XELODA 1250MG/M2 BID D1-14(2G BID) Q21D 7周期，末次化疗时间：2012.04.17。2、4周期疗效评价缩小的SD。6周期疗效评效SD。拟继续第8周期XELODA化疗。\\U0004\\U0004  患者诉第7疗程出现足底部皮肤浅皲裂，伴瘙痒，右足底为着。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 0, "end_pos": 6}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 14}, {"end_pos": 30, "label_type": "药物", "overlap": 0, "start_pos": 27}, {"end_pos": 35, "label_type": "药物", "overlap": 0, "start_pos": 31}, {"end_pos": 52, "label_type": "药物", "overlap": 0, "start_pos": 49}, {"end_pos": 56, "label_type": "药物", "overlap": 0, "start_pos": 53}, {"end_pos": 97, "label_type": "手术", "overlap": 0, "start_pos": 90}, {"end_pos": 112, "label_type": "药物", "overlap": 0, "start_pos": 109}, {"end_pos": 145, "label_type": "药物", "overlap": 0, "start_pos": 142}, {"end_pos": 171, "label_type": "药物", "overlap": 0, "start_pos": 165}, {"end_pos": 232, "label_type": "药物", "overlap": 0, "start_pos": 226}, {"end_pos": 326, "label_type": "药物", "overlap": 0, "start_pos": 320}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 352, "end_pos": 354}, {"end_pos": 368, "label_type": "解剖部位", "overlap": 0, "start_pos": 365}]}
